BlackRock Investment Management’s Cumberland Pharmaceuticals CPIX Stock Holding History

BlackRock Investment Management’s Portfolio CPIX Stock Details CPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$10K	Hold	1,900	–	–	﹤0.01%	3584
2016 Q3	$10K	Hold	1,900	–	–	﹤0.01%	3587
2016 Q2	$9K	Hold	1,900	–	–	﹤0.01%	3659
2016 Q1	$9K	Hold	1,900	–	–	﹤0.01%	3644
2015 Q4	$10K	Buy	1,900 +157	+9%	+$895	﹤0.01%	3677
2015 Q3	$10K	Hold	1,743	–	–	﹤0.01%	3682
2015 Q2	$12K	Sell	1,743 -192	-10%	-$1.33K	﹤0.01%	3640
2015 Q1	$13K	Hold	1,935	–	–	﹤0.01%	3554
2014 Q4	$12K	Hold	1,935	–	–	﹤0.01%	3601
2014 Q3	$10K	Buy	1,935 +221	+13%	+$1.07K	﹤0.01%	3658
2014 Q2	$8K	Buy	+1,714	New	+$7.65K	﹤0.01%	3709

Other funds holding CPIX

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

BlackRock Investment Management's CPIX Position: Q4 2016 in Review

BlackRock Investment Management held its Cumberland Pharmaceuticals (CPIX) position steady in Q4 2016 at 1,900 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #3584.

BlackRock Investment Management first reported a position in CPIX in Q2 2014 and has held it in 11 quarters since. The position peaked at $13K in Q1 2015. 41 funds tracked by Wall St. Rank hold CPIX as of Q4 2016.

BlackRock Investment Management held 1,900 shares of Cumberland Pharmaceuticals worth $10K as of Q4 2016.
BlackRock Investment Management left its Cumberland Pharmaceuticals share count unchanged in Q4 2016.
Cumberland Pharmaceuticals made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3584 holding.
BlackRock Investment Management first reported a position in Cumberland Pharmaceuticals in Q2 2014 and has held it in 11 quarters since.
BlackRock Investment Management's Cumberland Pharmaceuticals position peaked at $13K in Q1 2015.
41 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.